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Introduction
To date, a physiological function for Rhamm (receptor for hyaluro-
nan [HA]-mediated motility) has remained elusive. Analyses of 
animal models demonstrated instructive roles of Rhamm in tumori-
genesis and infl  ammatory diseases (Tolg et al., 2003; Nedvetzki 
et al., 2004; Zaman et al., 2005), consistent with evidence for a role 
of Rhamm in motility and proliferation/apoptosis in culture (Turley 
et al., 2002; Adamia et al., 2005). However, given that migration 
and proliferation/apoptosis are essential functions for morpho-
genesis and tissue homeostasis, it is surprising that genetic deletion 
of Rhamm does not affect embryogenesis or adult homeostasis.
Rhamm was originally isolated from subconfl  uent fi  bro-
blasts in culture (Turley, 1982) and subsequently cloned from 
mesenchymal cells (Hardwick et al., 1992). Antibodies pre-
pared against a shed form of Rhamm blocked HA-stimulated 
 fi broblast motility, suggesting that Rhamm is a cell surface 
protein able to transduce motogenic signaling in culture (Turley 
et al., 2002). Rhamm-bound HA was detected in cancer cell 
lines and shown also to occur in intracellular compartments/
structures, including the cytoskeleton, nucleus, and cytoplasm 
(Hascall et al., 2004; Adamia et al., 2005). These results suggest 
that Rhamm has both extracellular and intracellular functions. 
However, the role of Rhamm as a cell surface HA receptor be-
came controversial partly because cloning of the human (Wang 
et al., 1996; Hofmann et al., 1998; Crainie et al., 1999) and 
mouse genes (Hofmann et al., 1998) revealed an absence of 
both a signal peptide required for export through the Golgi/ER 
and membrane spanning domains common to most cell surface 
receptors. We now know that Rhamm resembles a group of intra-
cellular proteins that also lack these signature characteristics 
of classical cell surface proteins but that are nevertheless found 
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hamm (receptor for hyaluronan-mediated motility) 
is an hyaluronan binding protein with limited ex-
pression in normal tissues and high expression in 
advanced cancers. To understand its physiological func-
tions and identify the molecular mechanisms underlying 
these functions, we created mice with a genetic deletion of 
Rhamm. We show that Rhamm
−/− ﬁ  broblasts fail to re-
surface scratch wounds >3 mm or invade hyaluronan-
  supplemented collagen gels in culture. We identify a 
requirement for Rhamm in the localization of CD44 to the 
cell surface, formation of CD44–ERK1,2 (extracellular-
regulated kinase 1,2) complexes, and activation/subcellular 
targeting of ERK1,2 to the cell nucleus. We also show that 
cell surface Rhamm, restricted to the extracellular com-
partment by linking recombinant protein to beads, and 
expression of mutant active mitogen-activated kinase 
  kinase 1 (Mek1) are sufﬁ  cient to rescue aberrant signaling 
through CD44–ERK1,2 complexes in Rh
−/− ﬁ  broblasts. 
ERK1,2 activation and ﬁ  broblast migration/differentiation 
is also defective during repair of Rh
−/− excisional skin 
wounds and results in aberrant granulation tissue in vivo. 
These results identify Rhamm as an essential regulator of 
CD44–ERK1,2 ﬁ  broblast motogenic signaling   required 
for wound repair.
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at the cell surface and regulate multiple functions by transmitting 
signals across the cell membrane. Examples include epimorphin/
syntaxin-2 and autocrine motility factor/phosphoglucose isom-
erase (Radisky et al., 2003; Nickel, 2005). However, neither the 
physiological functions of proteins such as Rhamm nor the 
mechanisms by which these proteins regulate signaling path-
ways are known.
We isolated cell surface Rhamm as a motogenic factor re-
quired for rapid fi  broblast motility, and we and others also pro-
vided evidence for a role of both cell surface and intracellular 
Rhamm in G2M progression in culture (Turley et al., 2002; Adamia 
et al., 2005). We showed that Rhamm expression is high in 
  aggressive human fi  bromatoses (desmoid) tumors (Tolg et al., 
2003) and demonstrated that genetic deletion of Rhamm strongly 
reduced desmoid tumor initiation and invasion in a mutant ade-
nomatous polyposis coli and β-catenin–driven mouse model of 
this mesenchymal tumor. Fibroproliferative processes such as 
aggressive fi  bromatosis resemble proliferative/migratory stages 
of wound healing (Cheon et al., 2002). The expression of 
Rhamm is modulated during wounding (Lovvorn et al., 1998) 
and by fi  brogenic cytokines such as TGF-β (Samuel et al., 
1993). Because factors that regulate fi  broblast function play 
dual roles in wound repair and tumorigenesis (Park et al., 2000; 
Bissell and Radisky, 2001), we have assessed whether Rhamm 
is involved in response to injury using models of “wounds” with 
Rhamm
−/− (Rh
−/−) fi  broblasts in vitro as well as excisional skin 
wounds in vivo with Rh
−/− mice. We show that Rhamm loss re-
sults in defective migration in culture as a result of aberrant 
CD44–ERK1,2 (extracellular-regulated kinase 1,2) signaling. 
We also show that ERK1,2 activity is defective in early phases 
of skin repair in Rh
−/− mice and that this defect is associated 
with aberrant mesenchymal cell migration and differentiation.
Results
Fibroblast migration and invasion 
in culture requires Rhamm and ERK1,2
We and others have previously shown that Rhamm mediates 
cell migration on tissue culture plastic (Turley et al., 2002). 
To determine whether Rhamm is required for fi  broblast migra-
tion under more physiological settings and whether other pro-
teins compensate for loss of Rhamm expression, the motogenic 
behavior of Rh
−/− and wild-type (Wt) fi  broblasts were com-
pared using scratch wounds and 3D collagen gel assays, which 
are designed to mimic aspects of migration in vivo (Reid et al., 
2004). Signifi  cantly fewer Rh
−/− than Wt fi  broblasts migrated 
across 3-mm scratch wounds in culture (Fig. 1 A). Time lapse of 
wounds revealed that motility speed of Rh
−/− fi  broblasts was 
less than Wt (Fig. 1 A). To confi  rm that Rhamm expression is 
suffi  cient to restore migration to Wt levels, we expressed full-
length Rhamm (Rh
FL) cDNA in Rh
−/− fi  broblasts. This rescued 
migration defects (Fig. S1 a, available at http://www.jcb.org/
cgi/content/full/jcb.200511027/DC1). Thus, loss of Rhamm 
  expression results in an inherent migration defect related to 
a reduced ability of fi  broblasts to orient and locomote toward 
haptotactic cues rapidly.
The invasive properties of Rh
−/− versus Wt fi  broblasts 
were compared in 3D collagen type I gels (Fig. 1 B). Migration 
of   primary Rh
−/− dermal fi  broblasts into the PDGF/HA/collagen 
gel plug was reduced by 90% compared with Wt fi  broblasts 
(Fig. 1 B), indicating an intrinsic defect in haptotaxis and inva-
sion of Rh
−/− fi  broblasts. Rh
FL expression rescued these defects 
(Fig. S1 b).
We previously showed that Rhamm is required for acti-
vation of ERK1,2 in culture (Zhang et al., 1998). Fibroblast 
migration requires appropriate temporal regulation of signaling 
pathways such as ERK1,2, which provide cues for promoting 
and sustaining migration/invasion (Krueger et al., 2001). To 
determine whether ERK1,2 activity and/or subcellular tar-
geting is aberrant in Rh
−/− fi  broblasts and whether the loss 
of Rhamm is the direct cause of these defects, we quantifi  ed 
serum induction of ERK1,2 activity in Rh
−/− versus Rh
FL-
 rescued  Rh
−/− fi  broblasts using ELISA, Western blots, and con-
focal microscopy (Fig. 2). ELISA analysis showed activation of 
ERK1,2 in both Rh
FL-rescued and Rh
−/− fi  broblasts (Fig. 2 A), 
but activity was less and declined more rapidly in Rh
−/− cells 
(Fig. 2 A). Western blots confi  rmed these results (Fig. 2 B). 
Confocal analysis showed that active ERK1,2 are targeted to 
Figure 1.  Migration and invasion of 
Rhamm
−/− ﬁ  broblasts are impaired. (A) Mi-
gration into scratch wounds in 2D cultures (16 
h). Signiﬁ   cantly more Wt than Rh
−/− ﬁ  bro-
blasts migrate into 3-mm wound gaps in re-
sponse to serum. Mean and SEM; n  = 6 
randomly chosen areas. Wt ﬁ  broblasts migrate 
at a higher speed and for longer distances 
than Rh
−/− ﬁ  broblasts. Mean and SEM; n = 
30 cells. One of six experiments is shown. 
(B) Invasion into collagen gels (48 h). Diagram 
of a collagen gel invasion assay constructed 
with HA and PDGF in the central plug. A sig-
niﬁ   cantly greater number of Wt than Rh
−/− 
  ﬁ   broblasts migrate into the plug. Mean and 
SEM; n = 4 randomly chosen areas. One of 
six experiments is shown. *, P < 0.05.WOUND REPAIR IS ABERRANT IN RHAMM
−/− MICE • TOLG ET AL. 1019
the nucleus in both Rh
FL-rescued and Rh
−/− fi  broblasts, but 
  activity was signifi  cantly less in Rh
−/− cells (Fig. 2 C). A similar 
reduction in activated ERK1,2 was observed in other sub-
cellular compartments of Rh
−/− cells, including lamellae. These 
results suggest that Rhamm is required for sustaining ERK1,2 
activity in multiple subcellular compartments, a process that 
can affect fi   broblast motility and differentiation (Hornberg 
et al., 2005).
Rhamm, CD44, and ERK1,2 form 
complexes required for activating ERK1,2
CD44 is a commonly expressed, integral membrane adhesion 
and HA receptor that activates motogenic signaling cascades, 
  including ERK1,2 (Bourguignon et al., 2002). CD44 coassociates 
with ERK1,2 via adaptor proteins that bind to its cytoplasmic tail 
(Bourguignon et al., 2005; Marhaba et al., 2005). To begin to 
identify molecular mechanisms that are defi  cient in Rh
−/− fi  bro-
blasts, we fi  rst assessed whether Rhamm can coassociate with 
CD44 and whether both Rhamm and CD44 are required for acti-
vation of ERK1,2. CD44s protein was expressed in equivalent 
amounts in Rhamm-expressing and Rh
−/− fi  broblasts (Fig. 3 A). 
The ability of Rhamm, CD44, and ERK1,2 to associate with each 
other in Rh
FL-rescued fi  broblasts was demonstrated in pull-down 
assays (Fig. 3 B). Confocal analyses confi  rmed coassociation of 
these proteins in cell processes and CD44-positive perinuclear 
vesicles (Fig. 3). Both anti-CD44 and anti-Rhamm antibody signi-
fi  cantly reduced the intensity of nuclear phospho-ERK1,2 (Fig. 4, 
A and B), raising the possibility that CD44–Rhamm complexes 
are required for maximal activation of ERK1,2. To test this, the 
consequences of blocking Rhamm, CD44, and ERK1,2 moto-
genic functions on fi  broblast migration were measured.
Rhamm, CD44, and ERK1,2 are required 
for motility in response to serum and HA
Anti-Rhamm, anti-CD44 antibody, and a mitogen-activated 
  kinase kinase 1 (Mek1) inhibitor (UO126) signifi  cantly blocked 
serum-induced motility of Rh
FL-rescued but not Rh
−/− fi  bro-
blasts (Fig. 4, C and D), confi  rming that Rhamm, CD44, and 
ERK1,2 activity are required for optimal motility.
Signaling through CD44 and ERK1,2 are required for mo-
tility in response to HA (Bourguignon et al., 2005). We there-
fore next measured the motility of Rh
FL-rescued versus Rh
−/− 
fi  broblasts stimulated with HA. To render nontransformed cells 
sensitive to HA, fi  broblasts can be pretreated with PMA; this 
activates PKC-dependent processes, permitting motogenic re-
sponses to HA (Hall et al., 2001). Compared with PMA treat-
ment alone, a mixture of high molecular weight HA and 
oligosaccharides signifi   cantly promoted random motility of 
Rh
FL-rescued but not Rh
−/− fi  broblasts (Fig. 4 D). Motogenic 
stimulation by HA required cell surface Rhamm, as anti-Rhamm 
antibodies blocked a response to HA. The inability of HA to 
 increase  Rh
−/− fi  broblast motility was puzzling because these 
cells express similar levels of CD44s as Wt (Fig. 3 A). We sus-
pected that the localization of CD44 to the cell surface might be 
altered in Rh
−/− cells, as a reduced number of perinuclear 
CD44-positive vesicles, which can traffi  c to the cell surface 
(Robertson et al., 2006), were observed in Rh
−/− versus Rh
FL-
rescued fi  broblasts (Fig. 3 A).
Rhamm promotes surface display of CD44 
and codistribution of CD44 with ERK1,2
Adherent Rh
−/− fi  broblasts exhibited reduced CD44 surface 
display compared with Rh
FL-rescued fi  broblasts (Fig. 5 A). Both 
Figure 2.  Serum-induced ERK1,2 activation is defective in Rhamm
−/− 
  ﬁ  broblasts. (A) ELISA of total cellular phospho-ERK1,2. Active ERK1,2 levels 
are signiﬁ  cantly higher after serum stimulation in Rh
FL-rescued than in Rh
−/− 
ﬁ  broblasts. Values at 0 min were subtracted from values at 30 and 60 min. 
Mean and SEM; n = 3 replicates. One of three experiments is shown. 
(B) Western blots of phospho-ERK1,2. Rh
FL-rescued ﬁ  broblasts sustain serum-
induced ERK1,2 activity for 50 min compared with 10 min in Rh
−/− ﬁ  bro-
blasts. One of ﬁ  ve experiments is shown. (C) Confocal micrographs and 
image analysis of phospho-ERK1,2. Overall levels and nuclear (blue) tar-
geting of phospho-ERK1,2 (red) are reduced in Rh
−/− compared with Rh
FL-
rescued ﬁ  broblasts. Mean and SEM; n = 15 cells for each time point. One 
of four experiments is shown. *, P < 0.05.JCB • VOLUME 175 • NUMBER 6 • 2006  1020
Mek1 inhibition with UO126 (Fig. 5 A) and anti-Rhamm anti-
body (Fig. 5 A) reduced CD44 display. Rh
FL-rescued fi  broblasts 
also showed increased colocalization of CD44 with active 
ERK1,2, particularly in the cell nucleus and perinuclear vesi-
cles, compared with Rh
−/− fi  broblasts (Fig. 5 B). Anti-Rhamm 
antibody reduced colocalization of these proteins (Fig. 5 B). 
These results suggest a role for cell surface Rhamm in ERK1,2 
activation and, consequently, surface display of CD44. We next 
examined whether activation of ERK1,2 in the absence of 
Rhamm would have a similar effect.
Expression of activated Mek1 
or restoration of cell surface Rhamm 
rescues Rh
−/− ﬁ  broblast defects
Expression of active Mek1 restored sustained serum-induced 
ERK1,2 activity in Rh
−/− fi  broblasts (Fig. 6, A and B). This ef-
fect was not enhanced by coexpression of Rh
FL (Fig. 6 A). Mek1 
also restored migration of Rh
−/− fi  broblasts (Fig. 6 C) and pro-
moted CD44 display (Fig. 6 C). These results suggest that 
Rhamm and Mek1/ERK1,2 act on the same CD44-regulated 
motogenic signaling pathway because Mek1 can compensate 
Figure 3. CD44 coassociates with 
Rhamm and active ERK1,2. (A) CD44 
protein expression and distribution. 
Rh
−/− and Wt ﬁ  broblasts express simi-
lar levels of CD44 proteins (β-actin 
loading control). One of three experi-
ments is shown. Confocal analysis 
shows that CD44 (green) occurs mainly 
in vesicles with phospho-ERK1,2 (red; 
colocalization shown as white) after 
Rh
FL rescue. CD44 staining is amor-
phous and not associated with phos-
pho-ERK1,2 in Rh
−/− ﬁ broblasts. One of 
four experiments is shown. (B) Rhamm, 
CD44, and ERK1,2 form complexes. 
Recombinant Rhamm-GST protein–
  Sepharose (Rhamm-GST beads) pulls 
down CD44s, a possible CD44 variant 
(120 kD), and ERK1,2. One of three ex-
periments is shown. Confocal analysis 
conﬁ   rms that Rhamm (red) and CD44 
(green) colocalize (white) in processes 
of Rh
FL-rescued ﬁ   broblasts (no Triton 
X-100) and in vesicles (+Triton X-100). 
One of three experiments is shown.
Figure 4.  Cell surface Rhamm (CD168) and 
CD44 are required for ERK1,2 activity and 
  motility in response to FCS and HA. (A) Role of 
cell surface Rhamm in nuclear ERK1,2 activity. 
Rhamm antibody signiﬁ  cantly reduces levels of 
serum-induced nuclear phospho-ERK1,2. Mean 
and SEM; n = 25 cells. One of four experi-
ments is shown. (B) Role of CD44 in nuclear 
ERK1,2 activity. CD44 antibody signiﬁ  cantly 
reduces the levels of serum-induced nuclear 
phospho-ERK1,2. Mean and SEM; n  = 25 
cells. One of four experiments is shown. (C) 
Motility in response to FCS. Rh
FL expression in 
Rh
−/− ﬁ  broblasts signiﬁ  cantly increases motility. 
The dotted line is Rh
−/− ﬁ   broblast motility, 
which did not vary with treatment. Rh
FL rescue 
requires surface CD44 and ERK1,2 activity, as 
CD44 antibody or a Mek1 inhibitor (UO126) 
signiﬁ  cantly reduces motility. Rhamm antibody 
blocks Rh
FL-rescued but not Rh
−/− ﬁ  broblast 
  motility. Mean and SEM; n = 30 cells. One of six 
experiments is shown. (D) Motility in response 
to HA. Wt, but not Rh
−/−, ﬁ  broblasts increase 
random motility in response to HA. Rhamm anti-
body reduces HA-mediated motility of Wt but 
not Rh
−/− ﬁ  broblasts. Fibroblasts were ﬁ  rst ex-
posed to PMA to generate responsiveness to 
HA. Mean and SEM; n = 30 cells. One of four 
experiments is shown. *, P < 0.05.WOUND REPAIR IS ABERRANT IN RHAMM
−/− MICE • TOLG ET AL. 1021
for Rhamm in these functions. Both cell surface and intracellular 
Rhamm have been proposed to regulate functions associated 
with motility and to affect signaling cascades (Turley et al., 
2002; Adamia et al., 2005). The ability of anti-Rhamm antibody 
to mimic defective motogenic signaling of Rh
−/− fi  broblasts 
suggests a role for cell surface Rhamm in these functions but 
does not exclude an involvement of intracellular Rhamm. 
Blocking antibodies do not permit a direct assessment of the 
relative roles of cell surface versus intracellular Rhamm in cell 
functions. To directly assess the importance of cell surface 
Rhamm to motogenic signaling, we exposed Rh
−/− fi  broblasts 
to recombinant Rhamm linked to Sepharose beads to restrict it 
to the extracellular compartment.
Rhamm beads signifi  cantly stimulated motility of Rh
−/− 
fi  broblasts that contacted beads, whereas GST beads had no 
  effect (Fig. 7 A). Both anti-CD44 and anti-Rhamm antibody 
(unpublished data) signifi  cantly blocked Rhamm bead–stimulated 
motility. CD44 surface display was dramatically increased in 
Rh
−/− fi  broblasts contacting Rhamm beads (Fig. 5 A). Impor-
tantly, fi  broblasts defi  cient in both Rhamm and CD44 (Rh
−/−:
CD44
−/−) did not increase motility in response to Rhamm beads 
(Fig. 7 A). Collectively, these results indicate that cell surface 
Rhamm is required for CD44 display and motility but that intra-
cellular Rhamm proteins are not required for these functions. 
Furthermore, these results show that CD44 is required for the 
motogenic effect of cell surface Rhamm.
To understand the molecular mechanisms by which cell 
surface Rhamm promotes CD44 surface display and increased 
motility, we determined whether Rhamm bead–induced motil-
ity of Rh
−/− fi  broblasts requires ERK1,2 activity. Inhibition of 
Mek1 signifi   cantly reduced motility of Rh
−/− fi  broblasts  in 
contact with Rhamm beads (Fig. 7 A). Conversely, Rhamm 
beads signifi  cantly stimulated serum-induced ERK1,2 activity 
and translocation to the nucleus (Fig. 7 B). ERK1,2 activity was 
not as high as that of Rh
FL-rescued fi  broblasts, suggesting a 
possible role for intracellular Rhamm forms in maintaining 
maximal activity of these kinases. A role for CD44 in Rhamm 
bead–promoted ERK1,2 activity was shown by the ability of 
CD44 antibodies to block Rhamm bead effects and by the lack 
of Rhamm bead–induced ERK1,2 activity in Rh
−/−:CD44
−/− 
fi  broblasts. Because expression of Rhamm and CD44 are in-
creased during excisional skin wound repair (Lovvorn et al., 
1998) and fi  broblast migration and differentiation are essential 
components of successful excisional wound repair, we asked 
whether Rhamm loss alters repair of excisional skin wounds 
in vivo.
Rhamm expression is required to sustain 
ERK1,2 activity during granulation tissue 
formation in vivo
We have shown that Rh
−/− fi  broblasts exhibit defective activa-
tion and subcellular targeting of ERK1,2 via CD44. To prove 
that Rhamm is indeed a player in the physiological regulation 
of ERK1,2, their activity was quantifi  ed in fi  broblasts of Rh
−/− 
versus Wt wound granulation tissue. Wt granulation tissue 
 fi broblasts exhibited strong staining for active ERK1,2 3 d after 
wounding (Fig. 8). Staining intensity increased sixfold by 
day 7 and did not drop signifi  cantly until day 13. Rh
−/− granu-
lation tissue fi   broblasts also exhibited strong activation of 
ERK1,2 at 3 d after wounding but dropped dramatically by day 7 
and remained low at day 13 (Fig. 8). These differences in 
Rh
−/− versus Wt ERK1,2 activity were not due to decreases 
in total ERK1,2 protein levels because immunoblot analyses 
revealed that Rh
−/− and Wt granulation tissue expressed simi-
lar amounts of ERK1,2 protein (unpublished data). These re-
sults suggest that Rhamm expression is required for sustaining 
ERK1,2 activity in granulation tissue fi  broblasts in vivo as well 
as in culture.
Figure 5.  Cell surface Rhamm is re-
quired for CD44 display and complex-
ing with phospho-ERK1,2. (A) Effect of 
Rhamm and ERK1,2 activity on surface 
display of CD44. (a and d) Rh
−/− ﬁ  bro-
blasts; (b–f) Rh
FL-rescued ﬁ  broblasts. 
Live-cell immunoﬂ  uorescence  shows 
that Rh
−/− ﬁ   broblasts exhibit less sur-
face CD44 than Rh
FL-rescued ﬁ  bro-
blasts. A Mek1 inhibitor and Rhamm 
antibody block CD44 cell surface dis-
play. Recombinant Rhamm beads res-
cue display on Rh
−/− cells in contact 
with or close to beads. One of three 
experiments is shown. (B) Effect of 
Rhamm on CD44 and phospho-ERK1,2 
colocalization. Confocal micrographs 
and image analysis show that serum 
stimulates greater colocalization (white) 
of CD44 (green) and phospho-ERK1,2 
(red) in Rh
FL-rescued than Rh
−/− ﬁ  bro-
blasts, and colocalization is reduced 
by Rhamm antibody. Mean and SEM; 
n = 25 cells. One of four experiments 
is shown. *, P < 0.05.JCB • VOLUME 175 • NUMBER 6 • 2006  1022
MAPKs have been implicated in processes relevant to 
wound repair, including contraction, cell migration, and mes-
enchymal differentiation (Bost et al., 2005; Hornberg et al., 
2005). We therefore next examined the consequences of 
Rhamm loss and aberrant ERK1,2 signaling on wound repair 
in vivo.
Loss of Rhamm expression results 
in abnormal granulation tissue formation 
and resolution in skin wounds
We fi  rst confi  rmed that Rhamm expression increases during 
  repair of excisional wounds by analyzing wound Rhamm mRNA 
during the fi  rst 7 d after injury. RT-PCR analysis of uninjured 
skin confi  rmed low Rhamm expression (Fig. S2 a, available 
at http://www.jcb.org/cgi/content/full/jcb.200511027/DC1). 
A marked increase in Rhamm mRNA was obvious 1 d after 
  injury, and expression was increased until day 3, when mRNA 
levels began to drop. By day 7, the mRNA levels were only 
slightly higher than those observed in uninjured skin. These re-
sults indicate that Rhamm is expressed during wound contrac-
tion, reepithelialization, and early granulation tissue formation. 
The consequence of Rhamm loss for the integrity of these early 
processes was recorded.
Wt and Rh
−/− wounds both contracted by 1–3 d after in-
jury, but early contraction of Rh
−/− wounds was signifi  cantly 
reduced compared with Wt (Fig. S2 b). By day 14, Wt and 
Rh
−/− wounds appeared resolved at the macroscopic level 
(unpublished data). However, analysis of serial tissue sections of 
wound centers revealed signifi  cant reductions in contraction and 
obvious differences in the dermal structure of Rh
−/− wounds at 
all time points (Fig. S2 c). 21 d after injury, both the thickness 
and the cellularity of the remodeling dermis were signifi  cantly 
greater in Rh
−/− versus Wt wounds. In addition, the differen-
tiation of structures such as hair shafts and muscle within the 
wound site was reduced in Rh
−/− versus Wt wounds (Fig. S3 b, 
available at http://www.jcb.org/content/full/jcb.200511027/DC1). 
A signifi  cant decrease in the thickness of Rh
−/− versus Wt 
  dermis was also observed before injury (Fig. S3 a). These 
  observations are consistent with an ERK1,2-regulated defect in 
Rh
−/− wound fi  broblast function. We next analyzed the conse-
quences of Rhamm loss on granulation tissue formation/resolution, 
a process that is dependent on fi  broblasts.
A temporal defect in the formation and resolution of gran-
ulation tissue was confi  rmed in Rh
−/− versus Wt wounds (Fig. 9). 
Tenascin-positive granulation tissue was abundant in day 3 Wt 
wounds and began to decrease by day 7 (Fig. 9 A). At day 14, 
Wt wound granulation tissue was largely resolved (Fig. 9 A). 
In contrast, the area of tenascin-positive granulation tissue in 
day 3 and 7 Rh
−/− wounds was smaller than Wt. Rh
−/− day 14 
wounds were still strongly tenascin-positive and highly variable 
(Fig. 9 B), as the pattern of staining was “patchy,” in contrast to 
Wt (Fig. 9 A). An additional difference in Rh
−/− wounds was 
the transient appearance of a thick layer of subcutaneous adipo-
cytes in day 1–3 Rh
−/− wounds (Fig. 10 A; unpublished data). 
These results suggest that a prominent effect of Rhamm loss 
during wound repair may be a miscuing of signals required for 
a correct ratio of fi  broblasts to adipocytes that arise from pro-
genitor cells, which leads to aberrant regulation of granulation 
tissue formation and resolution.
Fibroplasia is a particularly prominent feature of 
granulation tissue in excisional skin wounds. The biological 
Figure 6.  Mutant active Mek1 rescues ERK1,2 activity, motility, and CD44 
surface display in Rh
−/− ﬁ  broblasts. (A) ELISA of active ERK1,2. Expression 
of Mek1 in Rh
−/− ﬁ broblasts restores serum-induced ERK1,2 activity. Values 
at 0 min were subtracted from values at 30 and 60 min. Mean and SEM; 
n = 3 replicates from one of three experiments. (B) Western blot of active 
ERK1,2. Western blots conﬁ  rm rescue of ERK1,2 activity by Mek1 in Rh
−/− 
ﬁ  broblasts. One of ﬁ  ve experiments is shown. (C) Motility and cell surface 
CD44 display. Expression of Mek1 in Rh
−/− ﬁ  broblasts  signiﬁ  cantly  in-
creases motility, which is blocked by anti-CD44 antibody. Mean and SEM; 
n = 30 cells from one of three experiments. Live-cell immunoﬂ  uorescence 
shows that Mek1 expression restores surface CD44 display in Rh
−/− ﬁ  bro-
blasts. The speciﬁ  city of the anti-CD44 antibody is demonstrated by a lack 
of ﬂ  uorescence in murine CD44
−/−:Rh
−/− ﬁ  broblasts. One of three experi-
ments is shown. *, P < 0.05.WOUND REPAIR IS ABERRANT IN RHAMM
−/− MICE • TOLG ET AL. 1023
 activities  of  fi  broblasts are key factors in the formation of early 
granulation tissue architecture (Reid et al., 2004). Robust fi  -
broplasia, as quantifi  ed by the density/unit area of granulation 
tissue fi  broblasts, was apparent in Wt wounds on day 3 and 
was increased by day 7 (Fig. 10 A). Myofi  broblasts, detected 
by smooth muscle actin staining, appeared in Wt wounds by 
day 7 (Fig. 10 B). Fibroplasia was observed in day 3 and 7 
Rh
−/− granulation tissue but was blunted and accompanied 
by a signifi  cant decrease in myofi  broblasts at day 7 (Fig. 10, 
A and B). The presence of abundant wound-edge adipocytes, 
indicated by the presence of vacuolated cells (Fig. 10 A, 
  arrow), was confi  rmed by staining with the lipophylic dye 
BODIPY493/503 (Gocze and Freeman, 1994; unpublished 
data). Rh
−/− cells explanted from both uninjured skin (day 0) 
and day 7 wounds expressed less smooth muscle actin and 
accumulated more lipid than explanted Wt cells (Fig. 10 C). 
Thus, deletion of Rhamm results in lower fi  broblast density 
as well as aberrant differentiation in Rh
−/− granulation tissue 
in vivo and in culture.
Discussion
Our study identifi  es Rhamm as a fi  brogenic factor that is re-
quired for temporal and spatial regulation of granulation tissue 
formation and resolution. An underlying signaling defect as-
sociated with Rh
−/− wounds is deregulated ERK1,2 activation, 
which promotes fi  broblast migration as well as mesenchymal 
cell differentiation. This conclusion is supported by the dem-
onstration that Rh
−/− fi  broblasts are unable to appropriately 
activate ERK1,2 in culture and exhibit migration defects as 
measured by several locomotion assays, and that these de-
fects are rescued by expression of mutant active Mek1. Our 
results further reveal an autocrine mechanism by which cell 
surface Rhamm promotes motility in culture. This form of 
Rhamm promotes ERK1,2 activation via an association with 
CD44, which in turn is required for maintaining cell surface 
display of CD44. ERK1,2 is acting “downstream” of cell sur-
face Rhamm in this function, as expression of mutant active 
Mek1 is suffi   cient to maintain cell surface CD44, activate 
ERK1,2, and restore motility in the absence of Rhamm 
  expression. This motogenic mechanism involves formation of 
cell surface Rhamm–CD44–ERK1,2 complexes and is ap-
parently required for both growth factor– and HA-mediated 
 motility.  These  fi  ndings identify for the fi  rst time a mecha-
nism by which Rhamm, a nonintegral membrane protein, can 
activate intracellular signaling cascades and provide a novel 
mechanism by which ERK1,2 promotes motility. Furthermore, 
our results suggest a previously unidentifi  ed role for ERK1,2 
activation kinetics in excisional skin wound granulation tissue 
formation/resolution.
Rhamm belongs to a group of proteins that are predomi-
nantly intracellular but can be exported to the cell surface via 
unconventional transport mechanisms that do not involve the 
export through the Golgi/ER (Nickel, 2005). We show that cell 
surface Rhamm is displayed in culture after injury, and our re-
sults have begun to clarify functions for cell surface Rhamm 
versus intracellular Rhamm forms. Although we did not set out 
to defi  ne a role for intracellular Rhamm, indirect evidence sug-
gests that it plays a role in mitotic events, at least in culture, as 
cell surface Rhamm did not rescue the abnormal mitosis ob-
served during time-lapse analysis of Rh
−/− fi  broblasts (unpub-
lished data). These results are consistent with evidence for 
intracellular Rhamm function during progression through G2M 
of the cell cycle (Mohapatra et al., 1996; Maxwell et al., 2003, 
2005) and its presence on centrosomes and mitotic spindle mi-
crotubules (Maxwell et al., 2003; Evanko et al., 2004). Never-
theless, our current data do not provide support for an essential 
role of either intracellular or cell surface Rhamm in mitotic 
spindle formation and cell cycle regulation during wound repair 
in dermal fi  broblasts in vivo, as judged by the lack of detectable 
Figure 7.  Cell surface Rhamm rescues 
motility of Rhamm
−/− ﬁ  broblasts. 
(A) Motility in response to Rhamm beads. 
Rh
−/− ﬁ  broblast motility is signiﬁ  cantly 
increased when cells contact recom-
binant Rhamm beads, compared with 
control GST beads. Rhamm bead–
stimulated motility is similar to Rh
FL-
rescued ﬁ  broblast motility and is blocked 
by a Mek1 inhibitor and CD44 anti-
body. Mean and SEM; n = 30 cells. 
One of eight experiments is shown. 
(B) ERK1,2 activation in response to 
Rhamm beads. Serum-induced ERK1,2 
activity (red; white in insets) in Rh
−/− 
ﬁ   broblasts is signiﬁ  cantly  stimulated 
by Rhamm beads but not control GST 
beads. ERK1,2 activity is not increased 
in Rh
−/− ﬁ broblasts when CD44 (green) 
is not expressed (Rh
−/−:CD44
−/−). 
Rhamm beads do not increase nuclear 
phospho-ERK1,2 in Rh
−/−:CD44
−/− 
ﬁ   broblasts. Mean and SEM; n = 25 
cells. One of three experiments is shown. 
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differences in proliferation or apoptotic indices within Rh
−/− 
versus Wt wound sites. The slightly disorganized migration of 
Rh
−/− fi  broblasts from scratch wound assays on tissue culture 
plastic is consistent with a possible centrosome defect that could 
contribute to aberrant migration (Watanabe et al., 2005) and 
merits further experimentation. A role for Rhamm in collagen 
contraction has been controversial in culture (Bagli et al., 1999; 
Travis et al., 2001). Unexpectedly, therefore, our studies sug-
gest that Rhamm is necessary for recruitment/differentiation of 
myofi  broblasts and contraction of the wound bed. As is increas-
ingly reported and recognized, both of these results emphasize 
the importance of context and the microenvironment in regu-
lating tissue-specifi  c signaling (Bissell et al., 2003). Thus, data 
obtained in culture, especially on 2D substrata, need to be con-
fi  rmed in vivo.
ERK1 and -2 are closely related MAPK isoforms that are 
activated by Mek1 or -2 and regulate signaling pathways that 
control cell motility, invasion, and cytoskeleton remodeling dur-
ing migration in culture (Yao et al., 2003; Bost et al., 2005). Our 
results show that migration defects of Rh
−/− fi  broblasts result 
from an inability to sustain and maximally activate ERK1,2 after 
growth factor stimulation. These results are consistent with our 
previous evidence that cell surface Rhamm is required for PDGF-
stimulated ERK1,2 activity in mesenchymal cells and for pro-
moting migration by regulating signaling through upstream 
activators of ERK1,2, including HA, Src, Ras, and FAK (Hall 
et al., 1995, 1996; Turley et al., 2002). Others have also docu-
mented a role for cell surface Rhamm in activating signaling cas-
cades that regulate motility and that directly or indirectly affect 
ERK1,2 activation (Lokeshwar and Selzer, 2000; Aitken and 
  Bagli, 2001; Goueffi  c et al., 2006). Although cell surface Rhamm 
can promote ERK1,2 activity to levels suffi  cient to sustain motil-
ity in the absence of intracellular forms, levels were lower than 
in cells expressing both cell surface and intracellular Rhamm 
(e.g., Rh
FL-rescued fi  broblasts). Furthermore, although cell sur-
face Rhamm–activated ERK1,2 translocated to the nucleus, 
  activity did not persist here as it did when intracellular Rhamm 
was also present. These results indirectly implicate intracellular 
Rhamm forms in aspects of ERK1,2 activation/compartmental-
ization. These intracellular defi  ciencies did not affect the ability 
of cell surface Rhamm to promote motility during our experi-
mental time frame but could affect other functions associated 
with ERK1,2 activity, such as invasion and mitosis, neither of 
which were rescued by cell surface Rhamm alone (unpublished 
data). The consequences of ERK1,2 signaling on cell differentia-
tion, migration, and proliferation depends on activation kinetics 
and subcellular compartmentalization (Colucci-D’Amato et al., 
2003; Hendriks et al., 2005; Hornberg et al., 2005). These factors 
are determined by receptor dimerization and internalization, 
cross talk with other receptors, association of ERK1,2 with adap-
tors, and activation of other kinases or phosphatases that modify 
ERK1,2 activity. Our study raises the possibility that cell surface 
and intracellular Rhamm may differentially affect the activation 
levels and subcellular targeting of ERK1,2, which have conse-
quences to motility- and invasion-related gene expression and 
phosphorylation of intracellular substrates that are involved in 
cell migration/invasion (Huang et al., 2004).
ERK1,2 regulate motility by both transcriptional and post-
translational mechanisms. For example, initiation and early 
phases of migration during wound repair do not require tran-
scription (Providence and Higgins, 2004) but, rather, involve 
phosphorylation of predominantly cytoskeleton-associated sub-
strates required for motility, such as myosin (Huang et al., 2004; 
Helfman and Pawlak, 2005; Simoes and Fierro, 2005). Our re-
sults also identify a role for ERK1,2 activity in sustaining cell 
surface display of CD44, an integral membrane protein required 
for motility in response to growth factors and HA (Toole, 2004). 
ERK1,2 promote recycling of clathrin-negative early endo-
somes back to the cell surface, a pathway associated with re-
cycling of β1 integrins and E-cadherin (Robertson et al., 2006). 
A similar ERK1,2-regulated recycling event may be responsible 
for maintaining CD44 at the cell surface.
We have shown that CD44 and Rhamm have overlapping 
functions in regulating migration events and that Rhamm can 
Figure 8.  ERK1,2 activation is aberrant in Rhamm
−/− wound granulation 
tissue. Both Wt and Rh
−/− granulation tissue ﬁ  broblasts are positive for 
phospho-ERK1,2 on day 3 after wounding (brown). ERK1,2 activity signiﬁ  -
cantly increases in Wt wound granulation tissue by day 7 and drops to 
background by day 14. ERK1,2 activity prematurely drops in Rh
−/− wound 
granulation tissue to background at day 7 and remains low at day 14. 
Mean and SEM; n = 15 images of three serial sections of wounds from ﬁ  ve 
Wt and Rh
−/− mice. *, P < 0.05.WOUND REPAIR IS ABERRANT IN RHAMM
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compensate for loss of CD44 in aspects of splenocyte migration 
into arthritic joints, although the reverse may not be true 
(Nedvetzki et al., 2004). These and other studies (Turley et al., 
1993; Goueffi  c et al., 2006) suggest that Rhamm can promote 
cell motility independently of CD44. Very likely, in these 
  instances, cell surface Rhamm associates with other adhesion 
receptors involved in cell motility, and partnering may depend 
on expression and cell surface display levels of these receptors, 
which will vary with the nature of disease, cell type, and temporal 
stage of wound repair.
Figure 9.  Wound granulation tissue forma-
tion/resolution is altered in Rhamm
−/− mice. 
(A) Tenascin protein expression in wound 
  sections. Wound granulation tissue is abundant 
in day 7 Wt mice (brown) and largely resolved 
by day 14, as indicated by loss of tenascin 
staining. In comparison, tenascin-positive 
Rh
−/− granulation tissue area is reduced on 
days 3 and 7 and “patchy” on day 14, sug-
gesting delayed and abnormal patterning of 
granulation tissue resolution. (B) Quantiﬁ  ca-
tion of tenascin-positive granulation tissue. Wt 
granulation tissue area is signiﬁ  cantly greater 
than Rh
−/− at both day 3 and 7 after wounding. 
Mean and SEM; n  = 3 serial sections of 
wound tissue composites from eight Rh
−/− and 
Wt mice. *, P < 0.05.
Figure 10.  Fibroblast density is reduced and 
wound granulation tissue cell heterogeneity is 
increased in Rhamm
−/− mice. (A) Fibroblast 
density in granulation tissue. Granulation tis-
sue ﬁ   broblast (elongated, vimentin-positive 
cells, brown) density is signiﬁ  cantly reduced in 
Rh
−/− versus Wt granulation tissue on days 3 
and 7 after injury. The arrow indicates a vacu-
olated cell (adipocyte). Rh
−/− ﬁ  broblast  den-
sity is heterogeneous (e.g., dotted circle is 
sparse; ﬁ  lled line circle is dense) and was aver-
aged per microscope ﬁ  eld. Mean and SEM; 
n = 4 serial sections of wounds from eight Wt 
and Rh
−/− mice. (B) Smooth muscle actin–
  positive granulation tissue ﬁ  broblasts. The num-
ber of wound myoﬁ  broblasts (α-smooth muscle 
actin–positive cells, brown) is signiﬁ  cantly re-
duced in day 7 Rh
−/− versus Wt wounds. 
Mean and SEM; n = 4 serial sections from 
wounds of eight Rh
−/− and Wt mice. *, P < 0.05. 
(C) Smooth muscle actin– and lipid-positive 
  ﬁ   broblasts (adipocytes) in wound explants. 
Smooth muscle actin–positive ﬁ  broblasts (red) 
are reduced, whereas lipid-containing cells 
(green) are increased in Rh
−/− versus Wt 
wound tissue explants. One of two experi-
ments is shown.JCB • VOLUME 175 • NUMBER 6 • 2006  1026
Materials and methods
Reagents
Medical-grade HA prepared from bacterial fermentation (a gift from Skye-
Pharma) was free of detectable proteins, DNA, or endotoxins (Filion and 
Phillips, 2001). The average molecular mass and polydispersity was 276.7 
and 1.221 kD, respectively. HA oligosaccharides (average molecular 
mass 10 kD; a gift from F. Winnik, University of Montreal, Montreal, Canada) 
were prepared by partial digestion with testicular hyaluronidase and 
puriﬁ  cation by gel ﬁ  ltration. The following primary antibodies were used: 
ERK1 (immunohistochemistry/Western blot), actin (Western blot), vimentin 
(immunohistochemistry),  α-smooth muscle actin (immunohistochemistry), 
nonimmune IgG (Santa Cruz Biotechnology, Inc.), Ki67 (immunohistochem-
istry; DakoCytomation), tenascin (immunohistochemistry; Chemicon), 
  phospho-ERK1,2 (immunohistochemistry/Western blot/immunoﬂ  uorescence; 
Cell Signaling), CD44 (Western blot/immunoﬂ  uorescence/blocking; IM7; 
BD Biosciences), CD44 (blocking; Hermes-3; a gift from D. Naor, The 
  Hebrew University of Jerusalem, Jerusalem, Israel), Rhamm (immunoﬂ  uores-
cence; ProSci), and Rhamm (blocking; Zymed Laboratories). Speciﬁ  city of 
Rhamm and CD44 antibodies were determined using Rh
−/− and CD44
−/− 
cells, respectively. The following secondary antibodies were used: anti-
  rabbit Alexa 555 and anti-rat Alexa 433 (Invitrogen), HRP-anti-mouse (Bio-Rad 
Laboratories), anti-rabbit (BD Biosciences), and anti-rat (Santa Cruz Bio-
technology, Inc.). ApopTag peroxidase in situ apoptosis detection kit 
(Chemicon) was used for quantiﬁ  cation of apoptosis, and FACE ERK1/2 
ELISA kit (Active Motif) was used to detect phospho-ERK1,2. Other reagents 
used were as follows: human plasma ﬁ  bronectin (BD Biosciences), PDGF 
(PDGF-BB), and PMA (Sigma-Aldrich); 50 μM PD098059 and 10 μM 
U0126 (BD Biosciences); collagen (Vitrogen100; Cohesion); Matrigel (BD 
Biosciences); immunoﬂ   uorescence mounting medium with DAPI (Vecta-
shield; Vector Laboratories); Cytoseal (Richard-Allan Scientiﬁ  c); and ABC 
staining system (Santa Cruz Biotechnology, Inc.). All antibodies and re-
agents were used according to the manufacturer’s instructions unless other-
wise stated.
Rh
−/− mice, mouse embryonic ﬁ  broblasts, and dermal ﬁ  broblasts
All animal experiments complied with the University of Western Ontario 
(London, Canada) animal use committee regulations. Preparation of Rh
−/− 
mice and mouse embryonic ﬁ  broblasts (Tolg et al., 2003) and CD44
−/− 
mice (Schmits et al., 1997) have been described. Rhamm and CD44 
heterozygous mouse mating generated Rh
−/−:CD44
−/− double-knockout 
mice. Dermal ﬁ   broblasts were isolated from newborn skin explants 
and granulation tissue cells from wound punch explants (cultured dermal 
side down).
Cell culture, transfection, and antibody blocking
Cell culture was done as described previously (Zhang et al., 1998; Tolg 
et al., 2003). 25 ng/ml PDGF, 500 ng/ml–1 mg/ml HA, or 10% serum 
(FCS) were added to 24-h serum-starved, 50% subconﬂ  uent ﬁ  broblasts 
plated on 25 μg/ml ﬁ  bronectin-coated dishes (Hall et al., 1996; Zhang 
et al., 1998). For HA responsiveness, cells were pretreated with 5 nM 
PMA (Hall et al., 2001). For antibody blocking experiments, serum-
starved cells were preincubated for 30 min with anti-Rhamm antibody, 
anti-CD44 antibody, or control IgG (10 μg/ml) before the addition of 
10% FCS. Immortalized Rh
−/− cells were transfected with murine Rh
FL 
and/or mutant active Mek1 (a gift from N. Ahn, University of Colorado at 
Boulder, Boulder, CO) using Lipofectamine Plus (Invitrogen) as described 
previously (Zhang et al., 1998) and were selected in 1–5 mg/ml G418 
(Sigma-Aldrich).
Time-lapse analysis
Cells were plated and stimulated with HA or PDGF. For FCS stimulation, 
  ﬁ  broblasts were plated onto serum-coated ﬂ  asks. Cells were ﬁ  lmed as 
  described previously (Zhang et al., 1998; Hall et al., 2001).
In vitro wound and invasion assays
Conﬂ   uent cell monolayers were starved overnight, scratch wounded 
(3 mm) with a sized cell scraper, and stimulated with FCS or PDGF for 
24–48 h. Monolayers were ﬁ  xed (3% paraformaldehyde), stained (0.1% 
methylene blue), and imaged. For 3D assays, collagen or Matrigel gels 
containing ﬁ  broblasts (5 × 10
5 cells/ml) were prepared with plastic in-
serts placed in the gel center. After 24–48 h, the inserts were removed 
and the cell free space was ﬁ   lled with collagen containing 25 ng/ml 
PDGF, 100 μg/ml HA, and 25 ng/ml ﬁ  bronectin. Gels were ﬁ  xed and 
analyzed 72 h later.
Western blots
Western blots of CD44, phospho-ERK1,2, and total ERK1,2 proteins were 
performed as described previously (Schmits et al., 1997; Zhang et al., 
1998; Tolg et al., 2003). Densitometry was performed using Image Quant 
5.1 software (Molecular Dynamics).
Immunoﬂ  uorescence of cultured cells
Immunoﬂ  uorescence of phospho-ERK1,2 was done as described previously 
(Avizienyte et al., 2004). Immunoﬂ  uorescence of CD44 and Rhamm was 
done using the same methods with overnight incubation of the primary anti-
bodies at 4°C. Live-cell CD44 immunoﬂ  uorescence was done as described 
previously (Robertson et al., 2006).
ERK1,2 assays
For quantiﬁ  cation of serum or PDGF-induced ERK1,2 activation, cells were 
plated, serum starved, and stimulated with 10% FCS or PDGF as described. 
Western blots and immunoﬂ   uorescence were done as described. The 
ERK1,2 ELISA was done according to the manufacturer’s instructions.
Recombinant proteins and pull-down assays
Rhamm-GST (72-kD murine isoform) and GST recombinant proteins were 
prepared as described previously (Mohapatra et al., 1996). For pull-down 
assays, recombinant Rhamm-GST or GST beads were incubated with 500 μg 
of Rh
FL-rescued lysate overnight at 4°C. Beads were then washed with cold 
lysis buffer. Proteins associated with beads were boiled in SDS buffer and 
were detected by Western blot as described.
Excisional wounds and histology
Wt and Rh
−/− mice were anaesthetized by Halothane inhalation. Two full-
thickness 4-mm wounds were placed at the same location on denuded 
backs of age-matched male mice (9–18 mo), were harvested at the indi-
cated times using an 8-mm metal punch, and were ﬁ  xed and parafﬁ  n em-
bedded as described previously (Tolg et al., 2003). To ensure that serial 
sections were cut starting at the wound center, samples were cut in half 
through the wound center before embedding. The ﬁ  rst and last sections 
were stained with Masson’s trichrome.
RT-PCR analysis of Rhamm mRNA
Rhamm mRNA was ampliﬁ  ed from excised wound tissue, and PCR prod-
ucts were detected as described previously (Tolg et al., 2003). β-Actin was 
used as a loading control (Tolg et al., 2003).
Immunohistochemistry of tissue sections
Immunohistochemistry of parafﬁ   n processed sections was done as de-
scribed previously (Tolg et al., 2003). Antigens were retrieved in 10 mM 
sodium citrate buffer, pH 6, heated to boiling, except for smooth muscle 
actin staining. Neutral lipids were detected in ﬁ  xed cultured cells or frozen 
wound sections with 25 μg/ml BODIPY 493/503 (Invitrogen; Gocze and 
Freeman, 1994).
Image acquisition, image enhancement, image analysis, 
and statistical analysis
Masson’s trichrome, hematoxylin and eosin, vimentin, tenascin, and phospho-
ERK1,2 stained tissue section images were taken with air objectives 
(4×, NA 0.16; 20×, NA 0.7; Olympus) on a microscope (AX70 Provis; 
Olympus) with a color camera (Cooke SensiCam; CCD Imaging) and 
  Image Pro Plus 4.5.1.2.9 (Media Cybernetics). Phospho-ERK1,2 staining was 
quantiﬁ  ed with Photoshop 6.0 (Adobe). The area of blue (hematoxylin, 
  total number of cells) was quantiﬁ  ed. After deletion of the blue pixels, the 
peroxidase substrate (phospho-ERK1,2) was quantiﬁ  ed. Tenascin staining 
was quantiﬁ  ed using Simple PCI (Compix). Images in Fig. 9 A are compos-
ites of images taken with the 4× air objective. The colors were enhanced 
using Photoshop. Scratch wound and surface CD44 immunoﬂ  uorescence 
images were taken with air objectives (4×, NA 0.1, and 20×, NA 0.4, 
respectively [Nikon], with Hoffman Modulation Contrast optics) using a 
  microscope (Eclipse TE300; Nikon) with a digital camera (Hamamatsu) and 
Simple PCI software. In vivo wound images (Fig. S2 a) were taken with 
a digital camera (Dimage Z3; Minolta) with a 12× zoom. The wound area 
was quantiﬁ  ed using Simple PCI. Confocal images were taken using an oil 
objective (63×, NA 1.4; Carl Zeiss MicroImaging, Inc.) with a confocal 
microscope (510 LSM Meta; Carl Zeiss MicroImaging, Inc.) using LSM 5 
software (Carl Zeiss MicroImaging, Inc.). Fluorescence intensity of images 
was measured using LSM 5 software. Colocalization was identiﬁ  ed and 
quantiﬁ  ed using ImageJ software (http://rsb.info.nih.gov/ij/). Cell surface 
CD44 images were deconvolved using Simple PCI’s nearest-neighbor WOUND REPAIR IS ABERRANT IN RHAMM
−/− MICE • TOLG ET AL. 1027
  deconvolution. All images were acquired at room temperature. Unless other-
wise indicated, comparisons between samples were assessed for statistical 
signiﬁ  cance using a t test; P < 0.05 was considered signiﬁ  cant, and signiﬁ  -
cant differences between values are marked with asterisks.
Online supplemental material
Fig. S1 shows that transfection of Rh
FL into Rh
−/− ﬁ  broblasts rescues defec-
tive migration in scratch wounds and invasion in collagen gel assays. Fig. 
S2 shows that Rhamm mRNA expression is transiently increased after exci-
sional skin wounding between days 1 and 7. Photographs of wounds show 
that Rh
−/− wounds contract more slowly than Wt. Tissue sections through 
excisional skin wounds conﬁ  rm that loss of Rhamm results in signiﬁ  cantly 
reduced wound contraction relative to Wt. Fig. S3 shows that the dermal 
structure of uninjured and repaired Rh
−/− skin is aberrant compared 
with Wt. This includes alterations in dermal thickness and in differentia-
tion of dermal cell types. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200511027/DC1.
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